Elixir Energy Ltd (EXR):企業の財務・戦略的SWOT分析

◆英語タイトル:Elixir Energy Ltd (EXR) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDGE2865FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:Oil and Gas
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Elixir Energy Ltd (Elixir Energy) is an independent oil and gas exploration and production company that acquires, explores, and develops conventional and unconventional oil and gas properties. The company’s projects include Petra project, Wattenberg project, and Moselle Permit. Its Petra project is located in Colorado and includes Arikaree Creek oil field, Great Plains oil field, John Craig oil field, and Snow King Discovery. Elixir Energy’s Moselle Permit is situated in north-eastern France in the Saar-Lorraine Basin and includes prospects such as Bullseye, Nancy East, and West Chaumont prospects. It has operations in Australia, France, the US and China. Elixir Energy is headquartered in Adelaide, South Australia, Australia

Elixir Energy Ltd Key Recent Developments

Feb 15,2021: Elixir Energy provides 2021 work program
Dec 09,2020: Elixir Energy announces prospective resources increased
Dec 03,2020: Elixir Energy provides operations update
Nov 23,2020: Elixir Energy announces operations update
Nov 23,2020: Elixir provides operations update

This comprehensive SWOT profile of Elixir Energy Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Elixir Energy Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Elixir Energy Ltd – Key Information
Elixir Energy Ltd – Overview
Elixir Energy Ltd – Key Employees
Elixir Energy Ltd – Key Employee Biographies
Elixir Energy Ltd – Key Operational Heads
Elixir Energy Ltd – Major Products and Services
Elixir Energy Ltd – History
Elixir Energy Ltd – Company Statement
Elixir Energy Ltd – Locations And Subsidiaries

Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Elixir Energy Ltd – Business Description
Elixir Energy Ltd – Corporate Strategy
Elixir Energy Ltd – SWOT Analysis
SWOT Analysis – Overview
Elixir Energy Ltd – Strengths
Elixir Energy Ltd – Weaknesses
Elixir Energy Ltd – Opportunities
Elixir Energy Ltd – Threats
Elixir Energy Ltd – Key Competitors

Section 3 – Company Financial Performance Charts

Elixir Energy Ltd – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Elixir Energy Ltd, Key Information
Elixir Energy Ltd, Key Ratios
Elixir Energy Ltd, Share Data
Elixir Energy Ltd, Major Products and Services
Elixir Energy Ltd, History
Elixir Energy Ltd, Key Employees
Elixir Energy Ltd, Key Employee Biographies
Elixir Energy Ltd, Key Operational Heads
Elixir Energy Ltd, Other Locations
Elixir Energy Ltd, Subsidiaries

Elixir Energy Ltd, Key Competitors
Elixir Energy Ltd, SWOT Analysis
Elixir Energy Ltd, Ratios based on current share price
Elixir Energy Ltd, Annual Ratios
Elixir Energy Ltd, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Elixir Energy Ltd (EXR):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Google LLC:企業の戦略的SWOT分析
    Google LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • DST Systems, Inc.:企業の戦略・SWOT・財務情報
    DST Systems, Inc. - Strategy, SWOT and Corporate Finance Report Summary DST Systems, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Peptimimesis SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary Peptimimesis SAS (Peptimimesis) is a biopharmaceutical company that discovers and develops transmembrane therapeutic peptides. The company’s proprietary platform delivers a set of drug candidates that act on strategic targets in the field of immuno-oncology, oncology and immune diseases. Its …
  • Isto Biologics:医療機器:M&Aディール及び事業提携情報
    Summary Isto Biologics is an orthobiologics company which manufactures and develops biological products to treat orthopedic and spine disorders. The company offers solutions in cell therapy, bone healing and regeneration that harness cells and proteins naturally found in human biology which support …
  • Iwatani Corporation (8088):企業の財務・戦略的SWOT分析
    Iwatani Corporation (8088) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Natco Pharma Ltd (NATCOPHARM):製薬・医療:M&Aディール及び事業提携情報
    Summary Natco Pharma Ltd (Natco Pharma) focuses on the research, development, manufacture and commercialization of pharmaceutical substances and finished dosage forms. The company offers finished dosage forms in capsule, injection and tablet. Its products are indicated to treat multiple sclerosis, i …
  • Claris Lifesciences Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Claris Lifesciences Ltd (Claris) is a manufacturer of generic drugs and pharmaceutical products. The company provides generic drugs that are directly injected into the human body, which is mainly used in the treatment of critical illnesses. It provides products are offered through various de …
  • ProPhotonix Limited (STKR):企業の財務・戦略的SWOT分析
    ProPhotonix Limited (STKR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Compass Minerals International Inc (CMP):企業の財務・戦略的SWOT分析
    Compass Minerals International Inc (CMP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Enyo Pharma SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Enyo Pharma SA (Enyo Pharma) is a biopharmaceutical company that develops molecules modulating host functions for the treatment of acute and chronic viral infections. The company provides technology which develops tools combining biological experimentation and computational development to id …
  • Stiefel Laboratories Inc-製薬・医療分野:企業M&A・提携分析
    Summary Stiefel Laboratories Inc (Stiefel Laboratories), a subsidiary of GlaxoSmithKline Plc is a healthcare products provider that develops products for sun care, dry skin and clear skin. The company also offers research and development, manufacture, marketing and distribution of prescription medic …
  • Biocodex Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Biocodex Inc (Biocodex), a subsidiary of Biocodex, is a pharmaceutical company that manufacturs and distributs probiotic drug products. The company provides products such as Saccharomyces boulardii CNCM I-745 that has a positive effect on the gut's microflora. It also provides Florastor, a y …
  • Dynavax Technologies Corp (DVAX):企業の財務・戦略的SWOT分析
    Dynavax Technologies Corp (DVAX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Mereo Biopharma Group Plc (MPH):製薬・医療:M&Aディール及び事業提携情報
    Summary Mereo Biopharma Group Plc (Mereo), formerly Mereo Biopharma Group Ltd is a specialty bio-pharmaceutical company which develops novel medicines for the treatment of rare and specialty diseases. The company’s pipeline products include BPS-804, which is used for the treatment of brittle bone sy …
  • Cargolux Airlines International S.A.:企業の戦略・SWOT・財務情報
    Cargolux Airlines International S.A. - Strategy, SWOT and Corporate Finance Report Summary Cargolux Airlines International S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • American International Group Inc:企業の戦略・SWOT・財務情報
    American International Group Inc - Strategy, SWOT and Corporate Finance Report Summary American International Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Innovotech Inc (IOT):医療機器:M&Aディール及び事業提携情報
    Summary Innovotech Inc (Innovotech) is a medical device company. The company offers services and solutions to medical, agricultural, and industrial problems caused by microbial biofilms. Its products include InnovoSIL, the antimicrobial agents for coating onto or incorporation into medical devices; …
  • Evolution Mining Ltd:企業のM&A・事業提携・投資動向
    Evolution Mining Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Evolution Mining Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Aarti Drugs Ltd (AARTIDRUGS):企業の財務・戦略的SWOT分析
    Summary Aarti Drugs Ltd (ADL), is a contract manufacturer of pharmaceutical products that offers therapeutic products, ingredients, bulk drugs, and chemicals. The company's products include active pharmaceutical ingredients, pharma intermediates, and specialty chemicals. Its active pharmaceutical in …
  • Enanta Pharmaceuticals Inc (ENTA):企業の財務・戦略的SWOT分析
    Summary Enanta Pharmaceuticals Inc (Enanta) is a biotechnology company. It discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. The company’s lead product candidate includes EDP-305, a farnesoid X receptor (FXR) agonist intended for the treatment of n …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆